INHIBITION OF SUCRASE-ISOMALTASE EXPRESSION BY EGF IN THE HUMAN COLON ADENOCARCINOMA CELLS CACO-2
INHIBITION OF SUCRASE-ISOMALTASE EXPRESSION BY EGF IN THE HUMAN COLON ADENOCARCINOMA CELLS CACO-2
复制标题
DOI:
10.1152/ajpcell.1991.261.6.c1173
复制
发表时间:
1991-12-01
影响因子:
--
通讯作者:
QUARONI, A
中科院分区:
文献类型:
--
作者:
CROSS, HS;QUARONI, A
To investigate the role and mechanism of action of epidermal growth factor (EGF) in the intestinal epithelium, we have studied its influence on proliferation and differentiation of Caco-2 cells, a human colon adenocarcinoma cell line exhibiting several characteristics of adult small intestinal enterocytes. A clone of Caco-2 cells synthesizing minimal amounts of transforming growth factor-alpha (TGF-alpha)/epidermal growth factor (EGF)-like activity was used in these studies. Cells grown in the presence of 20-200 ng EGF/ml exhibited increased DNA synthesis and proliferation; formation of morphologically poorly differentiated multilayers was observed at 200 ng EGF/ml. At all concentrations tested EGF produced a significant and marked reduction in sucrase activity, whereas other brush-border enzymes (aminopeptidase N, alkaline phosphatase, dipeptidylpeptidase IV) were only marginally affected. EGF influenced sucrase expression at two different levels. At 20 ng/ml, it affected primarily sucrase-isomaltase processing in the endoplasmic reticulum and/or increased its degradation. At 200 ng EGF/ml, a significant and marked reduction in sucrase-isomaltase mRNA levels and biosynthesis was observed. These results demonstrated that EGF has important and selective effects on Caco-2 cell proliferation and differentiation and may affect different cellular activities depending on its concentration.